Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta

The Boost Brittle Bones Before Birth (BOOSTB4) clinical trial is investigating the safety and efficacy of transplanting fetal derived mesenchymal stromal cells (MSCs) prenatally and/or in early postnatal life to treat severe Osteogenesis Imperfecta (OI). This study aimed to explore stakeholder views...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of human genetics : EJHG 2019-08, Vol.27 (8), p.1244-1253
Hauptverfasser:	Hill, Melissa, Lewis, Celine, Riddington, Megan, Crowe, Belinda, DeVile, Catherine, David, Anna L, Semler, Oliver, Westgren, Magnus, Götherström, Cecilia, Chitty, Lyn S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Attitude Child Children Clinical trials Decision making Female Fetal Stem Cells - transplantation Fetuses Fractures Humans Male Medical personnel Mesenchymal Stem Cell Transplantation - methods Mesenchymal Stem Cell Transplantation - psychology Mesenchymal stem cells Mesenchymal Stem Cells - cytology Mesenchyme Middle Aged Osteogenesis Osteogenesis imperfecta Osteogenesis Imperfecta - therapy Outcome Assessment, Health Care Parents & parenting Parents - psychology Patients Stem Cell Transplantation - methods Stem Cell Transplantation - psychology Stromal cells Transplantation Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!